In cholangiocarcinoma, MGMT methylation increases the number of cells entering S-phase by inhibiting p21, p27, and Cyclin E expression, which could be a possible explanation for the observed effects in the glioma cell lines (17). This evidence concerns the gene CCNE1 and central nervous system cancer.